X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2504) 2504
Publication (169) 169
Newsletter (71) 71
Conference Proceeding (27) 27
Book Review (23) 23
Book Chapter (6) 6
Dissertation (2) 2
Magazine Article (2) 2
Newspaper Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
verteporfin (2046) 2046
ophthalmology (1832) 1832
humans (1728) 1728
photodynamic therapy (1498) 1498
index medicus (1221) 1221
macular degeneration (1175) 1175
male (1170) 1170
female (1152) 1152
aged (1004) 1004
photochemotherapy (880) 880
middle aged (853) 853
fluorescein angiography (849) 849
ranibizumab (776) 776
choroidal neovascularization - drug therapy (705) 705
treatment outcome (690) 690
aged, 80 and over (609) 609
photosensitizing agents - therapeutic use (604) 604
choroidal neovascularization (589) 589
porphyrins - therapeutic use (580) 580
visual acuity (556) 556
bevacizumab (530) 530
retrospective studies (529) 529
tomography, optical coherence (518) 518
age-related macular degeneration (476) 476
visual acuity - physiology (476) 476
choroidal neovascularization - etiology (472) 472
follow-up studies (464) 464
macular degeneration - drug therapy (455) 455
vascular endothelial growth factor a - antagonists & inhibitors (437) 437
cancer (412) 412
angiogenesis inhibitors - therapeutic use (401) 401
intravitreal injections (385) 385
neovascularization (381) 381
adult (380) 380
prospective studies (333) 333
macular degeneration - complications (326) 326
subfoveal choroidal neovascularization (326) 326
care and treatment (318) 318
eye diseases (297) 297
antibodies, monoclonal, humanized (291) 291
vascular endothelial growth factor (285) 285
photochemotherapy - methods (280) 280
choroidal neovascularization - physiopathology (278) 278
optical coherence tomography (270) 270
angiogenesis inhibitors - administration & dosage (263) 263
endothelial growth-factor (255) 255
research (244) 244
verteporfin photodynamic therapy (243) 243
choroidal neovascularization - diagnosis (229) 229
injections (229) 229
indocyanine green (228) 228
medical imaging (225) 225
physiological aspects (213) 213
verteporfin therapy (212) 212
polypoidal choroidal vasculopathy (210) 210
randomized clinical-trial (208) 208
choroid - blood supply (205) 205
animals (204) 204
medicine & public health (202) 202
vitreous body (191) 191
injection (189) 189
macular degeneration - physiopathology (184) 184
intravitreal bevacizumab (182) 182
genetic structures (178) 178
retina (172) 172
antibodies, monoclonal - therapeutic use (168) 168
efficacy (163) 163
coloring agents (161) 161
secondary (159) 159
therapy (159) 159
wet macular degeneration - drug therapy (158) 158
age (155) 155
analysis (149) 149
antibodies, monoclonal, humanized - therapeutic use (149) 149
antibodies, monoclonal - administration & dosage (145) 145
safety (144) 144
diabetic retinopathy (141) 141
pathological myopia (141) 141
visual acuity - drug effects (138) 138
combined modality therapy (137) 137
retreatment (137) 137
laser photocoagulation (136) 136
fundus oculi (134) 134
avastin (132) 132
time factors (131) 131
studies (130) 130
central serous chorioretinopathy (129) 129
indocyanine green angiography (128) 128
sense organs (128) 128
patients (127) 127
surgery (127) 127
macular degeneration - diagnosis (124) 124
pharmacology & pharmacy (122) 122
photosensitizing agents - administration & dosage (120) 120
abridged index medicus (119) 119
antibodies, monoclonal, humanized - administration & dosage (118) 118
choroid diseases - drug therapy (115) 115
choroidal neovascularization - pathology (114) 114
myopia (114) 114
drug therapy, combination (112) 112
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2419) 2419
German (84) 84
French (53) 53
Korean (15) 15
Spanish (7) 7
Turkish (6) 6
Czech (5) 5
Portuguese (5) 5
Polish (3) 3
Hungarian (2) 2
Japanese (2) 2
Slovenian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2013, Volume 120, Issue 11, pp. 2292 - 2299
Purpose To assess long-term outcomes 7 to 8 years after initiation of intensive ranibizumab therapy in exudative age-related macular degeneration (AMD)... 
Ophthalmology | EYE | OPHTHALMOLOGY | MACULAR DEGENERATION | VERTEPORFIN PHOTODYNAMIC THERAPY | NATURAL-HISTORY | BEVACIZUMAB | Macular degeneration | Care and treatment | Patient outcomes
Journal Article
Journal Article
The FASEB Journal, ISSN 0892-6638, 10/2019, Volume 33, Issue 10, pp. 11469 - 11480
The cytokine IL-17A plays critical roles in the pathogenesis of autoimmune diseases. The frequencies of MAP kinase kinase kinase kinase 3 [also named germinal... 
Research | SLE | autoimmune disease | verteporfin
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 1395 - 9
Photodynamic therapy (PDT) is a promising cancer treatment modality that can selectively target unresectable tumors through optical activation of cytotoxic... 
CANCER | MULTIDISCIPLINARY SCIENCES | VERTEPORFIN
Journal Article
Chemico-Biological Interactions, ISSN 0009-2797, 10/2019, Volume 312, p. 108813
Rhabdomyosarcoma (RMS) is a pediatric tumor, which arises from muscle precursor cells. Recently, it has been demonstrated that Hippo Pathway (Hpo), a pathway... 
Verteporfin | YAP | Anti-proliferation | TAZ | Rhabdomyosarcoma | Cancer
Journal Article
by Ho, YF and Chao, A and Chen, KJ and Chao, AN and Wang, NK and Liu, L and Chen, YP and Hwang, YS and Wu, WC and Lai, CC and Chen, TL
PLOS ONE, ISSN 1932-6203, 05/2018, Volume 13, Issue 5
Background To investigate the treatment outcomes and predictors of response to photodynamic therapy (PDT) in patients with symptomatic circumscribed hemangioma... 
VERTEPORFIN | MULTIDISCIPLINARY SCIENCES | STURGE-WEBER-SYNDROME
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2014, Volume 8, Issue 8, p. CD005139
Journal Article
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, ISSN 0275-004X, 01/2008, Volume 28, Issue 1, pp. 85 - 93
Purpose: To evaluate the efficacy of a safety enhanced photodynamic therapy (PDT) protocol with half-dose verteporfin for treating chronic central serous... 
HALF DOSE VERTEPORFIN | optical coherence tomography | photodynamic therapy | verteporfin | HUMAN EYES | OPHTHALMOLOGY | MACULAR DEGENERATION | DETACHMENT | INDOCYANINE GREEN ANGIOGRAPHY | CHOROIDAL NEOVASCULARIZATION | central serous chorioretinopathy
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2014, Volume 61, Issue 5, pp. 1088 - 1096
Background & Aims Although the growth suppressing Hippo pathway has been implicated in hepatocellular carcinoma (HCC) pathogenesis, it is unknown at which... 
Gastroenterology and Hepatology | Preneoplastic stages | HCC | Verteporfin | TCPOBOP | Hippo pathway | YES-ASSOCIATED PROTEIN | RAT | ORGAN SIZE CONTROL | REGENERATION | CELL-PROLIFERATION | LESIONS | CARCINOGENESIS | PATHWAY | HEPATOCELLULAR-CARCINOMA DEVELOPMENT | GASTROENTEROLOGY & HEPATOLOGY | TUMORIGENESIS | Adenoma, Liver Cell - drug therapy | Precancerous Conditions - etiology | Adenoma, Liver Cell - etiology | Humans | Middle Aged | Rats, Inbred F344 | Male | MicroRNAs - metabolism | Precancerous Conditions - metabolism | Phosphoproteins - metabolism | Liver Neoplasms - etiology | Precancerous Conditions - drug therapy | Young Adult | Liver Neoplasms, Experimental - metabolism | Carcinoma, Hepatocellular - drug therapy | Apoptosis Regulatory Proteins - genetics | Adult | Female | Antineoplastic Agents - pharmacology | Carcinoma, Hepatocellular - etiology | Protein-Serine-Threonine Kinases - metabolism | Gene Expression | Signal Transduction | Adenoma, Liver Cell - metabolism | Liver Neoplasms - drug therapy | Rats | Porphyrins - pharmacology | Liver Neoplasms, Experimental - etiology | Apoptosis Regulatory Proteins - metabolism | Animals | Liver Neoplasms, Experimental - drug therapy | Apoptosis Regulatory Proteins - antagonists & inhibitors | Liver Neoplasms - metabolism | Cell Line, Tumor | Aged | Cell Proliferation - drug effects | Mice | MicroRNAs - genetics | Adaptor Proteins, Signal Transducing - metabolism | Carcinoma, Hepatocellular - metabolism | Liver cancer | Health aspects | Index Medicus
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 07/2018, Volume 136, Issue 7, pp. 786 - 793
IMPORTANCE Polypoidal choroidal vasculopathy (PCV) is common in Asian populations, but an optimal treatment approach remains to be confirmed. OBJECTIVE To... 
OPHTHALMOLOGY | MACULAR DEGENERATION | VERTEPORFIN PHOTODYNAMIC THERAPY | SHORT-TERM EFFICACY | COMBINATION | RANIBIZUMAB | Online First | Original Investigation | Research
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 05/2013, Volume 91, Issue 3, pp. e178 - e183
. Purpose:  Modern therapy of neovascular age‐related macular degeneration consists in intravitreal injections of inhibitors of the vascular endothelial growth... 
photodynamic therapy (Verteporfin®) | age‐related macular degeneration | Ranibizumab (Lucentis®) | choroidal neovascularization | vascular endothelial growth factor | ) | Ranibizumab (Lucentis | photodynamic therapy (Verteporfin | age-related macular degeneration | INTRAVITREAL RANIBIZUMAB | photodynamic therapy (Verteporfin (R)) | DOSING REGIMEN | TRIAL | Ranibizumab (Lucentis (R)) | VERTEPORFIN PLUS RANIBIZUMAB | DISEASE | AMD | OPHTHALMOLOGY | SUBFOVEAL CHOROIDAL NEOVASCULARIZATION | Prospective Studies | Intravitreal Injections | Photosensitizing Agents - therapeutic use | Humans | Middle Aged | Male | Wet Macular Degeneration - physiopathology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Photochemotherapy | Ranibizumab | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Microscopy, Acoustic | Visual Acuity - physiology | Fluorescein Angiography | Antibodies, Monoclonal, Humanized - therapeutic use | Porphyrins - therapeutic use | Tomography, Optical Coherence | Treatment Outcome | Combined Modality Therapy | Wet Macular Degeneration - diagnosis | Retreatment | Wet Macular Degeneration - drug therapy | Aged | Macular degeneration | Endothelial growth factors | Lasers in surgery | Physiological aspects | Ophthalmology | Neovascularization | Comparative analysis | Cancer | Drug therapy | Photodynamic therapy
Journal Article